The coronavirus has neurological consequences for the majority of hospitalized patients. Research published in "The Annals of Clinical and Translational Neurology" includes a study conducted on 509 Chicago COVID-19 patients since last spring. According to the document, 82% manifested at least one neurological consequence.
38% had headaches and 45% had muscle pain. Almost a third developed encephalopathies or "altered states of mind." 16% lost their sense of taste, 11% lost their sense of smell, and about 30% experienced dizziness. According to the study, the group of young patients was more likely to show neurological consequences. These neuropathies are not only prevalent in patients who are currently infected, but also in those who are recovering from the virus. In some cases, it is difficult to determine whether it is the virus or the treatment that produces these neurological consequences.
